COVID-19 has accelerated many changes in clinical research, particularly in the consumer healthcare space. While natural health products are increasingly attractive to consumers, the pandemic has caused significant disruptions to the clinical trial enterprise. Felix Alt, Head of Clinical Operations at Analyze and Realize, discusses both the challenges and the opportunities COVID-19 has brought to clinical research and consumer healthcare. Tune in to learn about:
- Why natural health products are increasingly attractive in COVID-19 times
- How this trend is shaping consumer’s health clinical research
- How Clinical Research Organisations (CROs) are adapting to the pandemic, including patient recruitment and the accelerated role of digitalisation
